You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

fulvestrant

Showing 1 - 25 of 250
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • +5 more
  • (no location specified)
Jun 7, 2023

Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Taipei City (Goserelin, Fulvestrant,

Recruiting
  • Premenopausal Breast Cancer
  • +2 more
  • Taipei City, Taiwan
    Department of Oncology, National Taiwan University Hospital
Feb 7, 2023

Breast Cancer Trial (Inavolisib, Fulvestrant, Alpelisib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jan 30, 2023

Breast Cancer Trial in Shanghai (Dalpiciclib, Fulvestrant, Pertuzumab)

Active, not recruiting
  • Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 10, 2022

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ocala, Florida
    Ocala Oncology Center PL DBA Florida Cancer Affiliates
Jul 19, 2023

Malignant Tumors of Female Genital Organs Trial in Houston (Fulvestrant, Abemaciclib)

Active, not recruiting
  • Malignant Neoplasms of Female Genital Organs
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 5, 2022

Breast Cancer Trial ([68Ga]Ga-NeoB, [177Lu]Lu-NeoB, Ribociclib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
May 22, 2023

Breast Cancer Trial in Shanghai (Chidamide, Abemaciclib, Fulvestrant)

Recruiting
  • Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 31, 2022

Breast Cancer Trial in Tianjin (Dalpiciclib, Pyrotinib, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • Tianjin, China
    Tianjin Cancer Hospital
Mar 28, 2023

Advanced Breast Cancer Trial in Seoul (Olaparib, Fulvestrant)

Not yet recruiting
  • Advanced Breast Cancer
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 12, 2022

ER-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Cancer Trial in Madison, Milwaukee (Onapristone, Fulvestrant)

Recruiting
  • ER-positive Breast Cancer
  • +2 more
  • Madison, Wisconsin
  • +1 more
Jul 7, 2022

Endometrial Cancer, Ovarian Cancer Trial in Houston (Copanlisib, fulvestrant)

Recruiting
  • Endometrial Cancer
  • Ovarian Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2022

Advanced Breast Cancer Trial in Thalassery (Alpelisib, Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • Thalassery, Kerala, India
    Novartis Investigative Site
Nov 21, 2022

Adenocarcinoma of Endometrium Trial in United States (Fulvestrant, Abemaciclib)

Recruiting
  • Adenocarcinoma of Endometrium
  • Basking Ridge, New Jersey
  • +6 more
Oct 12, 2022

ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer, a Germline or Somatic BRCA Mutation, or a

Recruiting
  • ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer
  • a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
  • Montpellier, France
  • +1 more
Nov 16, 2022

Breast Cancer Trial (Gedatolisib, Palbociclib, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Aug 12, 2022

Female Breast Carcinoma, Female Ductal Carcinoma In Situ Trial in Baltimore, New York (Fulvestrant)

Terminated
Has Results
  • Female Breast Carcinoma
  • Female Ductal Carcinoma In Situ
  • Fulvestrant
  • Baltimore, Maryland
  • +1 more
Mar 15, 2022

Advanced Solid Tumor, Breast Cancer Trial in Columbus, San Antonio, West Valley City (CFI-402257, Fulvestrant)

Recruiting
  • Advanced Solid Tumor
  • Breast Cancer
  • Columbus, Ohio
  • +2 more
Jul 26, 2022

Ovarian Cancer, Serous Ovarian Cancer Trial in Pittsburgh (Regorafenib, Fulvestrant)

Not yet recruiting
  • Ovarian Cancer
  • Serous Ovarian Cancer
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute
Apr 17, 2022

Advanced Breast Cancer Trial in Orebro (Alpelisib, fulvestrant)

Terminated
  • Advanced Breast Cancer
  • Orebro, Sweden
  • +1 more
Nov 21, 2022

Breast Cancer Trial in Aurora, New York, Germantown (Enzalutamide, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +2 more
Feb 22, 2022

Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Boston

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
Nov 3, 2022

Breast Cancer Trial in United States (Neratinib, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Indianapolis, Indiana
  • +5 more
Mar 2, 2022

Breast Cancer Trial in Worldwide (Ipatasertib, Placebo, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Atlanta, Georgia
  • +19 more
Dec 5, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • (no location specified)
Nov 8, 2022